Tuesday, December 27, 2016

Delivery Systems In Personal Care Market Research Report - Industry Analysis and Forecast to 2020 | Hexa Research

Delivery systems in personal care market are expected to grow over the forecast period owing to the increasing disposable income and growing product effectiveness. The other drivers of this market are changing lifestyle, increasing population, and technological advancements. Delivery system is one of the important integral parts of the personal care market, because it is very important that product should reach on time to their end customer. Both delivery system and personal care products are directly proportionate to each other. If the personal care market will grow than by default delivery system will also improve and vice-versa. Increasing disposable income is one of the key factors for this market, as people will have more disposable income in their hand, they will invest more on the personal care products.

Growing population is also one of the key factors. As population is increasing, the demands for personal care products are also increasing. So the met with the global demand, the personal care market should opt for better delivery system, otherwise company may face difficulties in sustaining in the market. There are huge unmet opportunities available for the investor or manufacturer. 


System Insights
Delivery systems in personal care market are segmented on the basis of forms, into foam delivery systems, activated delivery systems, starch-based systems and substrate-based systems. Among these, activated delivery systems held the largest market share as of 2013. The reason for its dominance is that it is controlled and activated by bio-chemical, chemical and physical facilities or processes by the energy supplied externally. The further segments of activated delivery systems are, classified into osmotic pressure activated, Hydrodynamic pressure activated, vapor pressure activated, mechanically activated, sonophorosis activated, Iontophoresis activated, and hydration activated. On the basis of products, the market is segmented into intomillicapsules, microcapsules, phospholipids and liposome’s based delivery systems. Liposome is the fastest growing market, as globally median age is increasing, so this product provides anti-ageing facility to look younger and beautiful. 

Regional Insights
Geographically, the Delivery systems in personal care market are studied with respect to four regions such as North America, Europe, Asia Pacific and RoW. North America is dominating the market followed by Europe, owing to the availability of strong delivery channel, consumer demands, huge variety of personal care products, availability of mass stores or luxury stores, better delivery system, presence of strong research & development, increasing advanced technologies and availability of disposable income. As we know that both North America and Europe are highly developed regions. People here in these regions are more concerned about their personal looks. So these people spend like a hell on the personal care products. In the upcoming forecast period, most of the domestic and international players are focusing on the emerging market, such as China and India, as these markets are lucrative in nature and owe towards untapped opportunity. These countries are growing rapidly in the personal care market. India and China are the world leader in the global population. As these countries are developing at a rapid rate, so market of personal care products has increased tremendously. People are investing a lot on the personal care products to look young and beautiful. 

Competitive Insights
The major market players in the delivery systems in personal care market are Norelco Consumer Products Company, Conair Corp, HoMedicsInc,Panasonic Corporation, GABA GmbH, Remington Products Company, Lipotec, Arch Chemicals, and BASF. As this market is highly competitive in nature, so the companies are focusing on the various strategies such as merger & acquisition, innovation, better customer service supports and collaboration to reduce competitions. Conair Corporation is one of the market leaders in this segment. It has always followed the strategy of acquiring newly established profitable companies. Few companies acquired by Conair Corporation are, in 1989, it acquired Cuisinart, in 1998 it acquiredWaring Products, in 2007 it acquired Allegro and in 2005, it acquired Jarden.


About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com

Friday, December 16, 2016

Smart Fitness Wear Market Analysis, Size, Share, Growth, Industry Trends and Forecast to 2024 | Hexa Research

The Smart fitness wear market is expected to grow at a CAGR of 30% over the forecast period from 2016 to 2024. Smart fitness wear are gaining popularity at a rapid pace. The major drivers identified for this growth are increasing demand for smart watches, smart wristbands, fitness & activity trackers, smart garments and clothing owing to surging consciousness regarding health and physical fitness, demand for technologically advanced products along with increasing need for innovative features and cost reduction of the key enabling technologies.
Surging demand for technologically advanced products with revolutionary features is prescribed to propel smart fitness wear market. Increasing usage of the products by athletes, trainers as a result of enhanced quality of workout, haptic alerts for workout regime driven the market consumption. Smart-textiles like t-shirt, leggings and socks are gaining popularity owing to accuracy of body workout on Smartphone. Advent of smart shoes and in-soles are further expected to boost market demand.
Smart fitness wear market is multi-industry market having varied applications in healthcare, sport, fashion, safety and military. Dominant sector for wearable is healthcare sector which merges wellness, fitness and medical for effective treatment of personnel. 
Browse Details of Report@
High price associated with smart fitness wear may scale down the market over the forecast period. Variable operating system platforms for different manufacturers, less integration with universal platforms, and difficult-to-use interface are expected to further curb demand. As low cost copies start to flood the market, competitive pressure will make it more difficult to sustain the current market pricing which subsidises the backend services and development. 
Disruptive technology in smart-textiles is expected to establish major demand from industrial, commercial and military applications over the forecast period. Rising innovative projects in electronics & healthcare industry is forecasted to provide massive growth prospects. Insurance firms are using smart fitness wear as a tool to improvise and outline member’s health is expected to propel market growth.
Social clothing lets a user to feel and share physical experience with the use of haptic sensors linked to an athlete’s or trainer’s clothing. Social clothing for sports fans is expected to be a key downstream smart textile market for manufacturer’s partnered with a sports club, fan club globally.
The smart fitness wear market can be segregated by end-use, product and region.
Based on end-use, market is further segmented into sports and fitness, personal medical and assisted living, kids and pets, fashion, and augmented realty. Sports and fitness industry constructed highest market share among the wearables and is likely to be typical high profile sector with lucrative growth opportunity. Personal medical and assisted living involves evolution of standard, connected medical devices such as thermometer, blood pressure meters for well and independent living. Low cost devices for kids and pets such as baby monitors, child trackers for monitoring the location or health constitute market opportunity for manufacturers.
Based on product, the smart fitness wear industry can be segmented in to shoes, in-soles, leggings, shirt, t-shirt, jackets, and bras. Major challenges in the product segment  is the need for a good fit so that the sensor remains in contact with the body means that multiple sizes for both genders will need to be supplied in any item of smart fitness sports clothing.  Companies looking for long term revenue in this area will need to find ways of developing compelling service models.
On the basis of region, smart wear market is segmented into Europe, Asia Pacific, the U.S and the U.K. Integration of smart wearable with wide platforms such as health data, diagnostic and virtual health trainer is expected to be lucrative opportunity for growth in the U.S market. Presence of leading industry participants is expected to exhibit moderate growth rate in Europe.
Asia Pacific is forecasted to experience significant growth owing to low production cost, prospering economies and rising consciousness among the masses. China owing to increasing commoditisation of wearable infotainment of basic electronic wristwatches and fitness wear is expected to gain market over the forecast period.
Adoption of GPS-enabled smart sports vests, smart watches directly connected to internet and accuracy in wearable’s data such as speed, distance are new technologies to look out for over the forecast period.
Apple, Samsung Electronics, Sony Corporation, Fitbit, Goqii, Garmin, Jawbone, Misfit, Sensoria, Xiaomi, ProtoGeo Oy (acquired by facebook) are global vendors of smart fitness wear market.
Fitbit gained a significant market share in smart watches vertical owing to its robust technology and accuracy in fitness tracking.
Qualcomm introduced a new processor for smart wearable targeted towards functions such as fitness trackers, smart headsets, and location aware gadgets for elderly and kids.
Sensoria, a smart-textile vendor, designed a pair of smart socks with embedded pressure sensors on the sole connected to the smart phone tracks pressure, speed, running style, ankle bend and distance of the trainer.

About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com

Friday, December 2, 2016

Dyslipidemia Therapeutics Market Research Report - Industry Analysis, Size and Forecast to 2024 - Hexa Research

Dyslipidemia is an interminable metabolic disorder, described by improper level of low thickness lipoprotein, high thickness lipoprotein, and triglycerides. The expanding demand and solutions of these medicines is offering lucrative growth opportunities for the dyslipidemia market. The current dyslipidemia business sector is overwhelmed by the statins, the progressive medications that diminish low-thickness lipoprotein cholesterol (LDL-C) and that have been demonstrated to lessen the danger of cardiovascular occasions, for example, heart assault and stroke. The launch of the proprotein convertase subtilisin/kexin type 9 (PCSK9) biologics and the cholesteryl ester transfer protein (CETP) inhibitors is anticipated to boost the industry growth. Nonetheless, loss of patent restrictiveness of particles, for example, crestor, zetia, and vytorin is required to hamper the development of the business sector amid the gauge time frame

Browse Details of Report@

The launch of PCSK9 inhibitors and human monoclobal antibody biologics to treat high LDL-C statins are expected to drive the industry demand.

PCSK9 Inhibitors is normally less utilized because of their potential for medication cooperation’s and poor patient resistance for side effects. The dispatch of the PCSK9s inhibitors might be approved by the U.S. food and Drug Administration (FDA) for use in the treatment of dyslipidemia. The PCSK9 inhibitors are sorts of prescriptions called monoclonal antibodies, which impersonate the body's own particular safe framework by joining to particular focuses on cells to create the desired result. While monoclonal antibodies are used to treat tumor, immune system illnesses and other conditions, they are widely used for the treatment of dyslipidemia.

High cholesterol, especially known as LDL-C, is the most widely recognized type of dyslipidemia. In information from the clinical system to date, Repatha has exhibited reliable, huge and solid diminishment in LDL-C levels with ideal consequences for other lipid parameters in around 6,000 patients with essential hyperlipidemia and blended dyslipidemia. Repatha, being produced by Amgen researchers, is intended to tie to PCSK9 and inhibit PCSK9 from official to LDL receptors on the liver surface. When PCSK9 are not there, there are more LDL receptors on the surface of the liver to expel LDL-C from the blood

The dyslipidemia drugs market can be segmented into bile acid resins, niacins, fibric acid derivatives, statins,  and others (cholesterol absorption inhibitors and combination drugs).
The statins section involves consolidated market revenue of statin drugs, for example, atorvastatin, fluvastatin, rosuvastatin, pravastatin, simvastatin, pitavastatin, and lovastatin. The bile acids segment included resins, for example, Cholestyramine, Colestipol, Colesevelam, and Cholybar. The fibric corrosive, and omega-3 unsaturated fat subsidiaries portion involves nonexclusive medications, for example, Fenofibrate, Clofibrate, and Bezafibrate. Other marked omega-3 unsaturated fats incorporate Lovaza, Vascespa, and Omtryg. Niacins incorporates medications, for example, Niaspan, Slo-Niacin, and Niacor. The others divisions includes market examination of drug therapy treatments, for example, Advicor, Vytorin, and Caduet, and in addition cholesterol inhibitor drugs.

Expanding frequencies of dyslipidemia in developed countries such as North America and Europe and in developing countries such as Asia Pacific and Latin America regions combined with rising number of solution for medications, for example, statins and fibric corrosive subordinates drives the dyslipidemia drugs market development. In 2014, North America ruled the worldwide dyslipidemia drugs market. Europe represented the second biggest offer i.e. around 25% of the aggregate business sector in 2014 inferable from the ideal development conditions for pharmaceutical producers because of moderateness for marked details by purchasers. As indicated by the Centers for Disease Control and Prevention, cholesterol variations are quickly expanding in countries like North America and Europe. Positive government endorsement strategies combined with predictable rateof dyslipidemia in these regions drives the development of dyslipidemia medications market in North America.

Some of the prominent players in the global dyslipidemia drugs market are Pfizer Inc., Novartis AG,Pfizer Inc.,Merck & Co., Inc.,Pfizer Inc., Inc., Abbott Laboratories,Amgen, Teva Pharmaceutical Industries Ltd.,Pfizer Inc.,  Bristol Myers Squibb Company., GlaxoSmithKline Takeda Pharmaceutical Company Limitedand others.

Browse Related Category Market Reports @

About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com
Follow us on Linkedin: https://www.linkedin.com/company/hexa-research

Friday, November 25, 2016

Emerging Insulin Drug and Delivery Technologies Market Analysis, Size, Share, Growth and Forecast to 2019 - Hexa Research

Globally, emerging technologies in the insulin drug and delivery field have shown potential in the diabetes market, with enhanced glucose control, along with well-accepted newer delivery methods. Contemporary industries, market players and research institutes have begun to explore novel methods for diabetes control in adults, leading to a steady market growth for these technologies.

Research and development spending, patent expiries, increasing competition and emerging technologies are expected to support the growth of this market. Technological advancements, new product launches, increased awareness and early detection of the disease have further influenced the market to develop in the foreseeable future.
The global market for insulin drug and delivery devices was estimated at USD 24.12 billion in 2012. Further the overall insulin drug and device market reached USD 25.72 billion by 2013 and is expected to grow at a CAGR of 9.6% from 2013 to 2019.

Browse Detail Report@

This research report provides comprehensive market statistics and forecast for key segments, and provides complete industry landscape including drivers, restraints, regulatory scenario, technology trends and future opportunities. The report also provides detailed competitive landscape with company market share analysis and in-depth profiles of key market participants. Key regional markets analyzed and reported in this study include:

North America
- Europe
- Asia Pacific
- RoW

Critical elements of the report include:
- Industry dynamics
- Market challenges and opportunities
- Technology & regulatory trends
- Market estimate and forecast
- Regional trends
- Competitive trends

Why should you buy this report?

- This report provides comprehensive analysis of the market including Porter’s and SWOT analysis
- Complete identification and analysis of key industry dynamics including drivers, restraints, raw material trends and buyer behavior
- The study provides technology landscape and regulatory trends for building strategy
- Global and regional market estimates and forecast on volume and revenue basis for multiple market segments
- Detailed competitive landscape of the market, with profiles of key companies

Browse Related Category Market Reports @

About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com
Follow us on Linkedin: https://www.linkedin.com/company/hexa-research

Tuesday, October 18, 2016

Electrical Hospital Beds Market Research Report - Industry Analysis, Size, Growth and Forecast to 2024 | Hexa Research

Exceptional access to a universe of data has offered ascend to the engaged, yet doubtful, customer. So is the situation with medicinal services, where the patient has been rendered more educated and reliable on account of the exceptional infiltration of the Internet. The perceiving persistent now requests more moderate, advanced, straightforward, and customized social insurance administrations, making the requirement for new models for consideration. The healing center beds industry taking into account treatment has made gigantic development in the late years.

The developing acknowledgment of intense consideration beds, basic consideration quaint little inns term beds have expanded the interest for doctor's facility beds. The business sector is developing with high development rate, because of a few variables, for example, developing maturing population, rising social insurance use, expanding pervasiveness of chronic diseases and mechanical progressions in doctor's facility beds. These beds are all around furnished with specific elements that permit patients to change the tallness, and in addition the head and foot segments of the bed. Besides, these components permit better situating of patients, enhanced blood course of patients because of development, simplicity of exchange, and security if there should arise an occurrence of patients, who are at a danger of dropping out of the bed because of the nearness of bed rails.

Browse Detail Report@

Expanding commonness of chronic diseases, development of maturing population and rising medicinal services use drives the business sector of electric beds globally. Increment in chronic diseases prompts an expansion in the quantity of hospitalization cases, fuelling the interest for clinic beds. Also, rising human services consumption overall prompts a change in the social insurance base bringing about development and remodel of healing centers with establishment of new doctor's facility beds. Hence, this drives the worldwide doctor's facility beds market

The innovative progressions in hospital facility beds are further likewise heightening the business sector universally. The electric hospital beds with force sleeping cushions for continuous weight redistribution with fitted electric engine enhance blood flow and aides keeping the development of bed injuries. These propelled highlights offered by these beds make them famous and prompts the development of the business sector around the world.
The maturing population will drive interest for doctor's facility beds, as more individuals require industry items for their medical consideration, including at-home restorative consideration. Moreover, producers will present new items with the most recent advances, for example, coordinated scales and key signs screens, to empower request. In this manner, the Hospital Bed Manufacturing industry's income will keep on growing, in accordance with predictable interest, new advancements and a maturing population.

The normal value that medicinal services offices paid for electric beds was 45% higher in February contrasted and that month a year ago. The expansion was powered by enthusiasm for beds intended for concentrated consideration units. The normal cost paid for electric beds was $15,627, as per the most current information in the Technology Price Index. Higher-cost ICU beds represented 40% of all enthusiasm for electric beds among ECRI part associations, up from 20% amid the same time the prior year. ICU beds tend to cost amongst $25,000 and $30,000 each-fundamentally more than restorative/surgical beds, which regularly cost $5,000 to $10,000 a bed

The key limitations connected with clinic beds business sector is their high cost. High cost of beds declines the reasonableness of individuals in low salary areas. Different hospitals offer several beds, for example, electrical beds, birthing beds, bariatric beds, and basic consideration are to a great degree costly, which makes them excessively expensive for doctor's facilities with restricted spending plan allotted for social insurance. In emerging nations, for example, India, China, and Brazil, manual and semi-electrical beds are favored over electric beds owing to their low cost. High cost of doctor's facility bed is expected to hamper the development of the Electrical Hospital Beds Market
Major players in the Electrical Hospital Beds Market include Linet Invacare Corporation, Hill Rom, Stryker, Getinge AB, Paramount Bed Co. Ltd, Gendron Inc., Span America Medical Systems Inc., and Medline Industries Inc among others.

Browse Related Category Market Reports @

About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com

Wednesday, August 3, 2016

Healthcare IT Market Analysis, Size, Share, Growth, Analysis and Forecast Period From 2014, 2020: Hexa Research

Healthcare IT market is expected to grow over the forecast period owing to the increasing prevalence of chronic disorders such as diabetes, cardiovascular diseases, and cancer. The other drivers for this market are government initiatives to provide better healthcare facilities for its people and the need for excellent healthcare systems to curb expenses. The use of information technology in the healthcare sector is to develop, implement and improve information systems for the industry. The main objective of healthcare IT is to decrease paperwork, improvement of healthcare quality, enhance healthcare accuracy, increase efficiency and by reducing error while maintaining medical records. The other benefits attached to this market are reducing healthcare costs by computerizing processes and helps in providing the real time data, so that these data can be retrieved as per the requirement. Till 2012, the global healthcare IT was valued at USD 36.15 billion and it is expected to grow at a double digit CAGR i.e. 14.2% during 2014 to 2020. As the popularity of the computerized physician order entry (CPOE) adaptation is increasing, so that error in regards to medical records could be controlled. Healthcare IT has a huge opportunity over the forecast period as it has an ability to identify and detect infectious and chronic diseases and will push government to expedite the adoption process. 
Browse Detail Report with TOC @
Application Insights

Healthcare IT market is segmented on the basis of application into computerized provider order entry systems, electronic health records, PACS, lab information systems, electronic prescribing systems, telehealth and telemedicine. Among these, telehealth and telemedicine are dominating the whole market. Telehealth is one the best example of collaboration between technology and healthcare. With the help of telecommunication technologies we can deliver the healthcare services and information. Increasing incidences of chronic diseases such as, hypertension, chronic obstructive pulmonary disease (COPD), asthma and diabetes is also the factor increasing the demand for home healthcare. Changing preferences of patients for avoiding hospital stays is also a major factor driving this market. There had been a lot of technological advancements introduction in the area of telecommunication such as, TEEVE (Tele-immersive environment for everybody) and SIP (session initiation protocol). As of 2013, electronic health records witnessed the largest revenue share as it constantly records and update the patient information, based on the encounters reported by healthcare establishments. This system is user friendly and interoperability are the significant features of this system. Additionally, it is very effective tool during the case of emergency as it provides real time information. 

Regional Insights

Geographically, the Healthcare IT market is studied with respect to four regions such as North America, Europe, Asia Pacific and RoW. Among these North America is dominating the whole market as it has strong presence of R&D, and increasing sophisticated healthcare infrastructure. U.S government has implemented industry friendly initiatives and introduction of incentive programs such as, EHR (electronic health records) by Medicare and Medicaid. In the recent years Europe has shown the tremendous growth. The privately held hospitals such as Helios and Sana, covers huge opportunities for future growth and with high unmet medical needs in European countries, such as Russia and Poland will drive the European healthcare IT market. Asia Pacific market is expected to show fruitful CAGR during the forecast period owing to the rapidly developing healthcare infrastructure are improving patient awareness, and various government initiatives.

Competitive Insights

The major market players in the Healthcare IT market are, Philips Healthcare, Agfa Healthcare, Mckesson Corporation, Carestream Health,GE Healthcare, E-MDS Inc., eClinicalworks, Athenahealth Inc., Carestream Health and Hewlett-Packard.

Enquire before purchasing the “Healthcare IT Market" Report@
Table of Contents

Chapter 1. Executive Summary
1.1. Healthcare IT - Industry Summary and Critical Success Factors (CSFs)

Chapter 2. Healthcare IT Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Healthcare IT Market Dynamics
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Healthcare IT - Company Market Share Analysis
2.7. Healthcare IT Market PESTEL Analysis, 2012

Browse Full Report @

About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com

Global Bioinformatics Market Analysis, Size, Share, Growth, Industry Trends and Forecast, 2014 To 2020: Hexa Research

The rising incidences of chronic diseases globally coupled with the increasing demand of advanced drugs for the diagnosis of these diseases are expected to propel the growth for bioinformatics market. The implementation of information technology to manage biological information efficiently is known as bioinformatics. Decreasing cost of DNA sequencing, continuous advancement in information technology support for bioinformatics devices and increasing aids from government & private sector organizations for bioinformatics are some of the key factors which are triggering the growth of bioinformatics market over the forecast period. Apart from these, the factors like increasing initiatives by research institutions for discovery of novel drugs in life science and significant growth in usage of bioinformatics in the field of clinical diagnostics are few supporting drivers of this market. Bioinformatics include genome annotation, gene sequence analysis, cancer mutation analysis, gene expression analysis, gene regulation analysis, protein expression analysis, comparative genomics and system biology. Continuous up-gradation in technology like cloud computing and nanopore technology has created a huge platform for storing, retrieving, analyzing, manipulating and organizing biological information. Adoption of computer technology for managing biological information also helps in developing drug and manage huge database associated which its discovery.
Browse Detail Report with TOC @
Sectors Insights

The global bioinformatics market is segmented on the basis of sectors, products & services and application. On the basis of sector, market is further classified into medical biotechnology, animal biotechnology, academics, agriculture biotechnology, forensic biotechnology, environment biotechnology and others. Medical biotechnology is further divided into drug development, molecular medicines, clinical diagnostics, gene therapy and reproductive biotechnology. Forensic biotechnology is the fastest growing segment owing to increasing demand for DNA as evidence in our legal system. Medical biotechnology is contributing highest share in the entire bioinformatics sector market due to involvement of huge sunk cost.

Products and Services Insights

On the basis of products and services, bioinformatics market is divided into bioinformatics knowledge management tools, bioinformatics platform and bioinformatics services. Bioinformatics tool is bifurcated into specialized knowledge management tools and generalized knowledge management tools. Bioinformatics platforms is further classified into sequence analysis platforms, sequence manipulation platforms, sequence alignment platforms, structural & functional analysis platform, whereas bioinformatics services is classified into sequencing service, data analysis, database management and other services. Among all the mentioned sub segments, database management and data analysis is the critical and expensive part owing to involvement of technology for organizing data and humans for interpretation.

Application Insights

On the basis of application, market is segmented into genomics, proteomics, chemo informatics & drug design, transcriptomics, metabolomics, molecular phylogenetic and others. Genomics is expected to be the largest market segment by 2020 owing to its ability to understand even the most complex biological system like brain, whereas metabolomics is anticipated to be the fastest growing segment over the forecast period in order to decrease risk factors and identify biomarkers which helps to reveal embryo during pregnancy.

Regional Insights

Geographically, North America was the most dominant region in entire bioinformatics market, in 2014. Due to increasing adoption of latest technology, and continuous discovery & development of drugs, this market is expected to maintain its lead by 2020. Asia Pacific region is anticipated to show highest growth during the forecast period owing to the rapid increase in CRO activities, huge investment for introduction of IT in healthcare, growing medical tourism and growing academic and industry partnership. Countries like India, China and Brazil is expected to provide significant growth opportunities owing to increasing research outsourcing by pharmaceutical giants of developed nations.

Enquire before purchasing the “Bioinformatics Market" Report@

Competitive Insights

Some of the key market players of bioinformatics market are Affymetrix, Inc., Biomax Informatics AG, Agilent Technologies, Inc., CLC Bio, Illumina, Inc., Integromics S.L., Geneva Bioinformatics S.A., Id Business Solutions, Life Technology Corporation, ABM, Nonlinear Dynamics Ltd., Qiagen, Perkin Elmer and Dnanexus. Since the market is highly competitive, monopolistic and consolidated. Firms are adopting many strategies for the development of their business and creating differences with other firms who are serving the same market.

Table of Contents

Chapter 1. Executive Summary
1.1. Bioinformatics - Industry Summary and Critical Success Factors (CSFs)

Chapter 2. Bioinformatics Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Bioinformatics Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Bioinformatics Market PESTEL Analysis, 2012


About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com